Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scipio bioscience is a Paris-based life sciences company that develops innovative solutions for single-cell RNA sequencing. The company's primary goal is to democratize single-cell analysis by providing a benchtop kit that eliminates the need for complex microfluidics or expensive specialized equipment. Their flagship product, the Asteria kit, utilizes a proprietary hydrogel technology for cell barcoding, which is complemented by Cytonaut, a cloud-based software platform for end-to-end data analysis. By simplifying the workflow, Scipio bioscience enables researchers to perform high-quality single-cell studies directly in their own laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scipio Life Sciences.